The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for EL Lorthiois


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.EBI
Novartis Institutes For Biomedical Research
PYRROLE DERIVATIVE OR PHARMACEUTICALLY OR SITOLOGICALLY ACCEPTABLE SALTS THEREOF, AND COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF GASTROINTESTINAL DISORDERS COMPRISING SAME AS ACTIVE INGREDIENTBDB
Hana Pharm
METHODS FOR TREATING A PULMONARY DISEASE WITH AN ALK-5 (TGF BETA R1) INHIBITORBDB
Thirona Bio
Process route of compound of formula (IV), crystal form and preparation method thereforBDB
Shandong Danhong Pharmaceutical Co.
Naphthyridinone compounds as JAK2 V617F inhibitorsBDB
Incyte
Design, Synthesis, and Experimental Validation of Peptide Ligands Targeting Mycobacterium tuberculosis s Factors.BDB
Indian Institute of Science
Biochemical and structural analysis of an Eis family aminoglycoside acetyltransferase from bacillus anthracis.BDB
University of Kentucky
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitorsBDB
Amgen
Inhibitors of protein kinasesBDB
Portola Pharmaceuticals
Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticalsBDB
Sanofi
Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors.BDB
Lanzhou University
Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.BDB
Taisho Pharmaceutical